With post-pandemic Medicaid enrollments on the decline and expected to fall further, revenue cycle leaders warn that ...
When hospitals overcharge insurers for drugs they bought at deep 340B discounts, taxpayers, employers, and insured patients ...
The federal 340B Drug Pricing Program, which requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to healthcare organizations that care for ...
Effective compliance now spans transaction eligibility, OPAIS synchronization, Medicaid exclusion validation, cost-report ...
Drug manufacturers participating in the Section 340B Drug Pricing Program now face a significant new litigation risk under the False Claims Act (“FCA”). In a recent decision, Adventist Health System v ...
Minnesota's 340B drug discount program faces scrutiny as small clinics struggle and large hospitals profit, sparking ...
In our January 14 blog, we explained that Chief Judge Lance Walker of the U.S. District Court for the District of Maine had entered a nationwide preliminary injunction in American Hospital Association ...
A proposal that would expand access to a federal program that discounts the price of prescription drugs could end up costing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results